Breakthrough brands, defined as those brands either introduced within the 52 weeks ended Dec. 25, 2016, or those brands that experienced blockbuster incremental growth in that time frame, feature leading meal-replacement solutions.
Specialty and biotech medicines aimed at treating cancer, multiple sclerosis and rare diseases will dominate much of drug development in 2017 and beyond, one of the nation’s top specialty pharmacy providers concluded.
Sales of durable medical equipment and the kind of home health products that help transition patient care from hospital settings to the home in the retail setting have only one direction to go. And that’s up.
Sales of all OTC medicines and natural supplements broke records in 2016, reaching $45.8 billion for the 52 weeks ended Dec. 25, 2016, according to IRI. That’s an additional $1.8 billion in sales volume compared with a year ago.